Repotrectinib (TPX-0005), effectively reduces growth of ALK driven neuroblastoma cells
- DOI
- 10.1038/s41598-019-55060-7
- Published
- 2019-12-18
- Container
- Scientific Reports
- Publisher
- Springer Science and Business Media LLC
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1038/s41598-019-55060-7,
title = {Repotrectinib (TPX-0005), effectively reduces growth of ALK driven neuroblastoma cells},
author = {Diana Cervantes-Madrid and Joanna Szydzik and Dan Emil Lind and Marcus Borenäs and Mats Bemark and Jean Cui and Ruth Helen Palmer and Bengt Hallberg},
year = {2019},
journal = {Scientific Reports},
doi = {10.1038/s41598-019-55060-7},
url = {https://doi.org/10.1038/s41598-019-55060-7}
}RIS
TY - JOUR TI - Repotrectinib (TPX-0005), effectively reduces growth of ALK driven neuroblastoma cells AU - Diana Cervantes-Madrid AU - Joanna Szydzik AU - Dan Emil Lind AU - Marcus Borenäs AU - Mats Bemark AU - Jean Cui AU - Ruth Helen Palmer AU - Bengt Hallberg PY - 2019 JO - Scientific Reports DO - 10.1038/s41598-019-55060-7 UR - https://doi.org/10.1038/s41598-019-55060-7 ER -
APA
Cervantes-Madrid, D., Szydzik, J., Lind, D. E., Borenäs, M., Bemark, M., Cui, J., Palmer, R. H., & Hallberg, B. (2019). Repotrectinib (TPX-0005), effectively reduces growth of ALK driven neuroblastoma cells. Scientific Reports. https://doi.org/10.1038/s41598-019-55060-7
Source records
- crossref · retrieved 2026-09-25T18:53:57.289Z